(VIANEWS) – MAGNORA (MGN.OL), SEADRILL (SDRL.OL), MONTEA (MONT.BR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MAGNORA (MGN.OL)
210.1% sales growth and 52.28% return on equity
Magnora ASA operates as a renewable energy development company. It primarily focuses on developing wind and solar photovoltaic (PV) projects. The company also hold license agreements with the Dana Western Isles and Shell Penguins FPSO. It serves oil companies and marine contractors in the United Kingdom, Norway, and Sweden. The company was formerly known as Sevan Marine ASA and changed its name to Magnora ASA in October 2018. Magnora ASA was incorporated in 2001 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, MAGNORA has a trailing twelve months EPS of kr4.01.
PE Ratio
MAGNORA has a trailing twelve months price to earnings ratio of 7.71. Meaning, the purchaser of the share is investing kr7.71 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.28%.
Yearly Top and Bottom Value
MAGNORA’s stock is valued at kr30.90 at 01:20 EST, way below its 52-week high of kr38.60 and way above its 52-week low of kr19.80.
Moving Average
MAGNORA’s worth is under its 50-day moving average of kr33.51 and higher than its 200-day moving average of kr28.86.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Oct 26, 2023, the estimated forward annual dividend rate is 0.37 and the estimated forward annual dividend yield is 1.17%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MAGNORA’s EBITDA is 8.39.
More news about MAGNORA.
2. SEADRILL (SDRL.OL)
63.5% sales growth and 4.22% return on equity
Seadrill Limited provides offshore contract drilling services to the oil and gas industry worldwide. It operates in three segments: Harsh Environment, Floaters, and Jack-ups Rigs. The company owns and operates drill ships, semi-submersible rigs, and jack-up rigs for operations in shallow and ultra-deep-water in benign and harsh environments. It serves oil super-majors, state-owned national oil companies, and independent oil and gas companies. Seadrill Limited was formerly known as Seadrill 2021 Limited. The company was incorporated in 2005 and is headquartered in Hamilton, Bermuda.
Earnings Per Share
As for profitability, SEADRILL has a trailing twelve months EPS of kr663.07.
PE Ratio
SEADRILL has a trailing twelve months price to earnings ratio of 0.72. Meaning, the purchaser of the share is investing kr0.72 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.22%.
Volume
Today’s last reported volume for SEADRILL is 86519 which is 15.86% below its average volume of 102833.
Revenue Growth
Year-on-year quarterly revenue growth grew by 67.2%, now sitting on 1.14B for the twelve trailing months.
More news about SEADRILL.
3. MONTEA (MONT.BR)
25.8% sales growth and 5.79% return on equity
Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specialises in logistical property in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space to grow through versatile and innovative property solutions. In this way, Montea creates value for its shareholders. As of 30/09/2023 the property portfolio represented a total surface of 1,921,172 m² spread across 94 locations. Montea NV has been listed on Euronext Brussels (MONT) and Euronext Paris (MONTP) since the end of 2006.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €3.82.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 19.82. Meaning, the purchaser of the share is investing €19.82 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.79%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.5%, now sitting on 124.38M for the twelve trailing months.
Sales Growth
MONTEA’s sales growth is 5% for the ongoing quarter and 25.8% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MONTEA’s EBITDA is 19.41.
More news about MONTEA.
4. SALMAR (SALM.OL)
8.4% sales growth and 6.83% return on equity
SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, North America, Europe, and internationally. The company operates through Fish Farming, Sales & Industry, Icelandic Salmon, and SalMar Aker Ocean segments. It is involved in the broodstock, lumpfish, and smolt production activities; and marine-phase farming, harvesting, processing, and selling farmed salmon. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.
Earnings Per Share
As for profitability, SALMAR has a trailing twelve months EPS of kr6.56.
PE Ratio
SALMAR has a trailing twelve months price to earnings ratio of 88.96. Meaning, the purchaser of the share is investing kr88.96 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.83%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 36.3% and 90.5%, respectively.
More news about SALMAR.
5. AIRBUS (AIR.PA)
7% sales growth and 26.56% return on equity
Airbus SE engages in the design, manufacture, and delivery of aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft; freighter aircraft; and regional turboprop aircraft and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment engages in the development, manufacture, marketing, and sale of civil and military helicopters; and provision of helicopter related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military aircraft, such as combat, mission, transport, tanker aircraft, and their associated services; a range of civil and defence space systems for telecommunications, earth observations, navigation, science, and orbital systems; and unmanned aerial systems. This segment also offers missile and space launcher systems, as well as services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is based in Leiden, the Netherlands.
Earnings Per Share
As for profitability, AIRBUS has a trailing twelve months EPS of €5.08.
PE Ratio
AIRBUS has a trailing twelve months price to earnings ratio of 26.48. Meaning, the purchaser of the share is investing €26.48 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.56%.
Yearly Top and Bottom Value
AIRBUS’s stock is valued at €134.54 at 01:20 EST, under its 52-week high of €138.76 and way higher than its 52-week low of €86.52.
More news about AIRBUS.
6. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 16.03% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 22.6. Meaning, the purchaser of the share is investing kr22.6 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Moving Average
VISTIN PHARMA’s worth is under its 50-day moving average of kr23.11 and above its 200-day moving average of kr21.87.
Volume
Today’s last reported volume for VISTIN PHARMA is 508 which is 97.88% below its average volume of 24009.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VISTIN PHARMA’s EBITDA is 2.29.
More news about VISTIN PHARMA.
7. DASSAULT SYSTEMES (DSY.PA)
5.8% sales growth and 13.44% return on equity
Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS design software for mechanical and electronic printed circuit board design solutions, product data management, simulation, manufacturing, and technical communication; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for intersection of natural resources, infrastructure and urban planning; and BIOVIA that develops chemicals, biologics, and materials experiences. The company provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; energy and materials; home and lifestyle; construction, cities, and territories; consumer packaged goods and retail; marine and offshore; and business services. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.
Earnings Per Share
As for profitability, DASSAULT SYSTEMES has a trailing twelve months EPS of €0.78.
PE Ratio
DASSAULT SYSTEMES has a trailing twelve months price to earnings ratio of 54.71. Meaning, the purchaser of the share is investing €54.71 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.44%.
Volume
Today’s last reported volume for DASSAULT SYSTEMES is 171703 which is 84.73% below its average volume of 1124490.
Yearly Top and Bottom Value
DASSAULT SYSTEMES’s stock is valued at €42.67 at 01:20 EST, above its 52-week high of €41.99.
More news about DASSAULT SYSTEMES.
